Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

First-in-human study of [124I]JS-001 PET/CT and PET/MR in patients with melanoma

Aug. 5, 2020

AC Immune describes enhanced alpha-synuclein PET tracers

Aug. 5, 2020

Gallium-68-labeled denosumab synthesized for PET imaging of tumor microenvironment

Aug. 5, 2020

French researchers disclose TfR1-targeting antibodies

Aug. 4, 2020

Clinical evaluation of [18F]EKZ-001 PET radiotracer to quantify HDAC6 brain expression

July 31, 2020

[18F]SMBT-1 shows promise for imaging astrogliosis in Alzheimer's disease

July 31, 2020

[89Zr]DFO-elotuzumab as novel imaging agent in patients with MM

July 29, 2020

[124/131I]-MSK-PSMA1, a new radioiodinated theranostic agent for PSMA-positive prostate cancer

July 29, 2020

Adenosine A2A receptor PET radiotracer [18F]FLUDA characterized in vitro and in vivo

July 28, 2020

HS-201 studied in phase I for imaging of solid tumors

July 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.